Dan I Andersson
Title
Cited by
Cited by
Year
Antibiotic resistance and its cost: is it possible to reverse resistance?
DI Andersson, D Hughes
Nature Reviews Microbiology 8 (4), 260-271, 2010
17252010
Selection of resistant bacteria at very low antibiotic concentrations
E Gullberg, S Cao, OG Berg, C Ilbäck, L Sandegren, D Hughes, ...
PLoS Pathog 7 (7), e1002158, 2011
10242011
The biological cost of antibiotic resistance
DI Andersson, BR Levin
Current opinion in microbiology 2 (5), 489-493, 1999
9471999
Microbiological effects of sublethal levels of antibiotics
DI Andersson, D Hughes
Nature Reviews Microbiology 12 (7), 465-478, 2014
8572014
Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance
J Björkman, I Nagaev, OG Berg, D Hughes, DI Andersson
Science 287 (5457), 1479-1482, 2000
4932000
Persistence of antibiotic resistant bacteria
DI Andersson
Current opinion in microbiology 6 (5), 452-456, 2003
4692003
The biological cost of mutational antibiotic resistance: any practical conclusions?
DI Andersson
Current opinion in microbiology 9 (5), 461-465, 2006
4542006
Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori
B Björkholm, M Sjölund, PG Falk, OG Berg, L Engstrand, DI Andersson
Proceedings of the National Academy of Sciences 98 (25), 14607-14612, 2001
3992001
Virulence of antibiotic-resistant Salmonella typhimurium
J Björkman, D Hughes, DI Andersson
Proceedings of the National Academy of Sciences 95 (7), 3949-3953, 1998
3701998
Ohno's dilemma: evolution of new genes under continuous selection
U Bergthorsson, DI Andersson, JR Roth
Proceedings of the National Academy of Sciences 104 (43), 17004-17009, 2007
3402007
Persistence of antibiotic resistance in bacterial populations
DI Andersson, D Hughes
FEMS microbiology reviews 35 (5), 901-911, 2011
3342011
Predicting antibiotic resistance
JL Martínez, F Baquero, DI Andersson
Nature Reviews Microbiology 5 (12), 958-965, 2007
3122007
Mechanisms and consequences of bacterial resistance to antimicrobial peptides
DI Andersson, D Hughes, JZ Kubicek-Sutherland
Drug Resistance Updates 26, 43-57, 2016
2952016
Adaptation to the deleterious effects of antimicrobial drug resistance mutations by compensatory evolution
S Maisnier-Patin, DI Andersson
Research in microbiology 155 (5), 360-369, 2004
2722004
Biological cost and compensatory evolution in fusidic acid‐resistant Staphylococcus aureus
I Nagaev, J Björkman, DI Andersson, D Hughes
Molecular microbiology 40 (2), 433-439, 2001
2682001
Evolution of antibiotic resistance at non-lethal drug concentrations
DI Andersson, D Hughes
Drug Resistance Updates 15 (3), 162-172, 2012
2672012
Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis
DH Mariam, Y Mengistu, SE Hoffner, DI Andersson
Antimicrobial agents and chemotherapy 48 (4), 1289-1294, 2004
2542004
Biological costs and mechanisms of fosfomycin resistance in Escherichia coli
AI Nilsson, OG Berg, O Aspevall, G Kahlmeter, DI Andersson
Antimicrobial agents and chemotherapy 47 (9), 2850-2858, 2003
2442003
Selection of a multidrug resistance plasmid by sublethal levels of antibiotics and heavy metals
E Gullberg, LM Albrecht, C Karlsson, L Sandegren, DI Andersson
MBio 5 (5), 2014
2432014
Gene amplification and adaptive evolution in bacteria
DI Andersson, D Hughes
Annual review of genetics 43, 167-195, 2009
2412009
The system can't perform the operation now. Try again later.
Articles 1–20